01 1ScinoPharm Taiwan Ltd
01 1BORTEZOMIB
01 1Taiwan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-13
Pay. Date : 2016-08-18
DMF Number : 25665
Submission : 2011-12-30
Status : Active
Type : II
20
Scinopharm Taiwan Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 25665.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 13, 2017, and payment made on August 18, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
